A Mass Balance Study of [14C]ABSK011

Clinical trial NCT06896760 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06896760
Sponsor: Abbisko Therapeutics Co, Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2025-04-07
Primary completion: 2025-11-07
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.